Mark Corrigan - Net Worth and Insider Trading

Mark Corrigan Net Worth

The estimated net worth of Mark Corrigan is at least $0 dollars as of 2024-11-13. Mark Corrigan is the Director of Nabriva Therapeutics PLC and owns about 288 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in Mark Corrigan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Corrigan has not made any transactions after 2022-08-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Mark Corrigan

Mark Corrigan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Corrigan owns 6 companies in total, including WAVE Life Sciences Ltd (WVE) , Nabriva Therapeutics PLC (NBRVF) , and Novelion Therapeutics Inc (NVLNF) among others .

Click here to see the complete history of Mark Corrigan’s form 4 insider trades.

Insider Ownership Summary of Mark Corrigan

Ticker	Comapny	Transaction Date	Type of Owner
WVE	WAVE Life Sciences Ltd	2019-09-04	director
NBRVF	Nabriva Therapeutics PLC	2022-08-02	director
NVLNF	Novelion Therapeutics Inc	2018-08-09	director
		2017-03-01	director
		2015-06-05	director
		2023-07-18	director

Mark Corrigan Latest Holdings Summary

Mark Corrigan currently owns a total of 1 stock. Mark Corrigan owns 288 shares of Nabriva Therapeutics PLC (NBRVF) as of August 2, 2022, with a value of $0.

Latest Holdings of Mark Corrigan

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
NBRVF	Nabriva Therapeutics PLC	2022-08-02	288	0.00	0

Holding Weightings of Mark Corrigan

Mark Corrigan Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Corrigan has made a total of 1 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nabriva Therapeutics PLC is the sale of 412 shares on August 2, 2022, which brought Mark Corrigan around $1,956.

Insider Trading History of Mark Corrigan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Corrigan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Corrigan Ownership Network

Ownership Network List of Mark Corrigan

No Data

Ownership Network Relation of Mark Corrigan

Mark Corrigan Owned Company Details

What does WAVE Life Sciences Ltd do?

Who are the key executives at WAVE Life Sciences Ltd?

Mark Corrigan is the director of WAVE Life Sciences Ltd. Other key executives at WAVE Life Sciences Ltd include See Remarks Chris Francis , director & See Remarks Paul Bolno , and 10 percent owner Plc Glaxosmithkline .

WAVE Life Sciences Ltd (WVE) Insider Trades Summary

Over the past 18 months, Mark Corrigan made no insider transaction in WAVE Life Sciences Ltd (WVE). Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net sale of 69,838 shares made by Kyle Moran , a net purchase of 6,091,930 shares made by Plc Glaxosmithkline , and a net purchase of 2,000,000 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 364,822 shares of WAVE Life Sciences Ltd (WVE) in total and bought 2,791,930 shares, with a net purchase of 2,427,108 shares. During the past 18 months, 417,514 shares of WAVE Life Sciences Ltd (WVE) were sold and 8,091,930 shares were bought by its insiders, resulting in a net purchase of 7,674,416 shares.

WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

WAVE Life Sciences Ltd Insider Transactions

No Available Data

What does Nabriva Therapeutics PLC do?

Who are the key executives at Nabriva Therapeutics PLC?

Mark Corrigan is the director of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .

Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nabriva Therapeutics PLC Insider Transactions

No Available Data

What does Novelion Therapeutics Inc do?

Who are the key executives at Novelion Therapeutics Inc?

Mark Corrigan is the director of Novelion Therapeutics Inc. Other key executives at Novelion Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .

Novelion Therapeutics Inc (NVLNF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Novelion Therapeutics Inc (NVLNF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Novelion Therapeutics Inc (NVLNF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Novelion Therapeutics Inc (NVLNF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Novelion Therapeutics Inc Insider Transactions

No Available Data

What does CoLucid Pharmaceuticals Inc do?

Who are the key executives at CoLucid Pharmaceuticals Inc?

Mark Corrigan is the director of CoLucid Pharmaceuticals Inc. Other key executives at CoLucid Pharmaceuticals Inc include 10 percent owner Pappas Capital, Llc , 10 percent owner Lilly Eli & Co , and 10 percent owner Tvm Life Science Ventures Vii L.p. .

CoLucid Pharmaceuticals Inc (CLCD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CoLucid Pharmaceuticals Inc (CLCD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CoLucid Pharmaceuticals Inc (CLCD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CoLucid Pharmaceuticals Inc (CLCD)'s detailed insider trading history can be found in Insider Trading Tracker table.

CoLucid Pharmaceuticals Inc Insider Transactions

No Available Data

What does EPIRUS Biopharmaceuticals Inc do?

Who are the key executives at EPIRUS Biopharmaceuticals Inc?

Mark Corrigan is the director of EPIRUS Biopharmaceuticals Inc. Other key executives at EPIRUS Biopharmaceuticals Inc include Chief Business Officer Vincent Aurentz , Chief Financial Officer Thomas A. Shea , and director & Chief Executive Officer Amit Munshi .

EPIRUS Biopharmaceuticals Inc (EPRSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EPIRUS Biopharmaceuticals Inc (EPRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

EPIRUS Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Trevena Inc do?

Who are the key executives at Trevena Inc?

Mark Corrigan is the director of Trevena Inc. Other key executives at Trevena Inc include SVP & Chief Medical Officer Mark Demitrack , SVP & Chief Business Officer Robert T Yoder , and director & President & CEO Carrie L. Bourdow .

Trevena Inc (TRVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevena Inc Insider Transactions

No Available Data

Mark Corrigan Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Corrigan. Currently GuruFocus does not have mailing address information for Mark Corrigan.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.